Back to Search
Start Over
All roads lead to targeted diffuse large B-cell lymphoma approaches.
- Source :
-
Cancer Cell . Feb2022, Vol. 40 Issue 2, p131-133. 3p. - Publication Year :
- 2022
-
Abstract
- Two recent reports in the New England Journal of Medicine highlight the successful application of novel targeted therapies to improve the clinical outcomes of diffuse large B-cell lymphoma (DLBCL). These findings encourage us to pursue further mechanism-based therapeutic uses to make DLBCL curable in the era of precision medicine. [ABSTRACT FROM AUTHOR]
- Subjects :
- *DIFFUSE large B-cell lymphomas
*INDIVIDUALIZED medicine
Subjects
Details
- Language :
- English
- ISSN :
- 15356108
- Volume :
- 40
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Cancer Cell
- Publication Type :
- Academic Journal
- Accession number :
- 155152541
- Full Text :
- https://doi.org/10.1016/j.ccell.2022.01.013